media – Page 518 – DrugDu- Global Leading Pharmaceutical & Medical Device Platform

Johnson & Johnson Innovation Opens JLABS @ NYC In SoHo

Johnson & Johnson Innovation in collaboration with New York State and the New York Genome Center launched JLABS in New York Genome Center, New York City. The size of the new facility is 30,000 Sq. ft. The new facility will enable 30 biotech, medical device, pharmaceutical, consumer and health tech companies with 26 resident companies, including the four winners of the JLABS at QuickFire Challenge.
- Source: Pharmaceutical Online
- 755
- June 27, 2018
Company Insight Johnson & Johnson
Food Allergen Detector at $40

This keychain-sized portable allergen detector is called an Integrated Exogenous Antigen Testing System (IEAT). By placing a drop or a bit of food on a single use slide namely an ‘antigen extraction device’, it can detect the allergen and its quantity within 10 minutes by performing necessary chemical deconstruction.
- Source: mHealthSpot
- 886
- June 27, 2018
Allergies digital health mHealth Researches
Predict Your Diabetes Risk Levels by Checking Your Partner’s BMI

According to the WHO statistical report, around 1.5 million deaths are caused due to diabetes worldwide. With these statistics in mind, a research team from the University of Copenhagen and Aarhus University in Denmark conducted research on diabetes patients.
- Source: India Times
- 701
- June 27, 2018
BMI diabetes Researches
3 Homemade Tonics Against Autoimmune Diseases

We have listed three scientifically validated drinks which help to fight against autoimmune disorders.
- Source: Healthline
- 590
- June 27, 2018
autoimmune health tips Researches
FDA Approval for Eversense – Continuous Glucose Monitoring System

The FDA has finally approved to market the implantable continuous glucose monitoring system named Eversense, from Senseonics, in the United States.
- Source: MobiHealthNews
- 989
- June 27, 2018
diabetes digital health mHealth New Approvals
FDA Approval for Cannabis Based Epidiolex Medicine Against Seizures

Epidiolex, also known as purified cannabidiol was approved to treat Lennox-Gastaut syndrome and Dravet syndrome specifically in patients aged 2 and older. Both these conditions start during childhood. Recurrent seizures pose a huge risk of death.
- Source: FiercePharma
- 576
- June 27, 2018
FDA Medical marijuana New Approvals
Biotech Crinetics Therapeutics Raises $86 million in IPO

The San Diego-based biotech company Crinetics Therapeutics recently raised $86 million in an IPO. Prior to the new funding, the company received $63.5 million in series B funding and will see its lead asset through phase 2.
- Source: FierceBiotech
- 808
- June 26, 2018
biotech Clinical Trials endocrine disorders
Indian Healthcare Startup SigTuple Raised $19 Million AI Based Products Development

India, Bengaluru based SigTuple, a startup focusing on Artificial Intelligence for Healthcare has raised $19 million in their series B funding. The investment was led by IDG Ventures, pi Ventures Partners along with Accel, Axilor Ventures, VH Capital, Endiya Partners and Flipkart’s executive chairman Binny Bansal. The startup has also bagged venture debt from Trifecta Capital in this round. In an earlier investment round, the company raised $6.5 million from various investors.
- Source: Analytics India
- 722
- June 26, 2018
AI Company Insight digital health start ups
Glaukos Corporation to receive Pre-Market approval for Next-Gen iStent

The inject is developed to achieve the natural outflow of aqueous humor by making two patent bypasses through the trabecular meshwork, glaucomatous eyes the main source of resistance resulting in multi-directional flow through Schlemm’s canal
- Source: BioSpectrumAsia
- 562
- June 26, 2018
FDA medtech New Approvals Optometry
What are the Impacts of Multiple Stents?

A shocking report revealed that patients with multiple stents or having longer stent greater than 31.5mm could be associated with high risk of mortality. Around 4.5% of patients died within a year of angioplasty. Death occurred in patients between the age group 35-75, where most of the people were elderly. Similarly, more patients who received metal stents had to be re-hospitalized, compared to those who received sophisticated drug-eluting stents.
- Source: India Times
- 1,006
- June 26, 2018
coronary stent medical device Researches

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.